NCT01987323View on ClinicalTrials.gov

Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Ocular Hypertension
Interventions
DRUG

Subconjunctival injection of liposomal latanoprost

All Listed Sponsors
lead

Singapore Eye Research Institute

OTHER

NCT01987323 - Safety and Efficacy of Liposomal Latanoprost in Ocular Hypertension | Biotech Hunter | Biotech Hunter